Related Experiment Video
Updated: Jan 14, 2026

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
Published on: March 17, 2014
Airway Necrosis and Fungal Plaque Causing Central Airway Obstruction Due to Candida auris: A Case Report
Sofia Pouriki1, Theoni Agapitou1, Anastasia Kosmidou1
1Intensive Care Unit, General Hospital of Thoracic Diseases "Sotiria", Athens, GRC.
Abstract:
Candida auris is an emerging multidrug-resistant fungal pathogen associated with high morbidity and mortality, particularly in critically ill and immunocompromised patients. To our knowledge, airway-obstructing tracheobronchial disease due to C. auris has not been previously reported. An 80-year-old woman with multiple comorbidities, including myelofibrosis under erythropoietin therapy, presented with severe coronavirus disease 2019 (COVID-19) pneumonia. On admission, clinical findings included fever, cough, dyspnea, leukocytosis (20.3 K/µL), elevated C-reactive protein (23.9 mg/dL), and procalcitonin (2.12 ng/mL). Chest CT revealed diffuse consolidations and ground-glass opacities. Progressive hypoxemia necessitated intubation and mechanical ventilation. The clinical course was complicated by ventilator-associated pneumonia caused by multidrug-resistant Acinetobacter baumannii, treated according to antibiogram results. Severe neuromuscular weakness prevented extubation, leading to tracheostomy. Shortly thereafter, progressive respiratory failure developed. Bronchoscopy demonstrated extensive necrosis and narrowing of the trachea. Tissue biopsy and cultures confirmed C. auris infection. Histopathology demonstrated fungal spores and septate hyphae within necrotic tracheobronchial mucosa on periodic acid-Schiff/Grocott methenamine-silver (PAS/GMS) stains, consistent with tissue invasion rather than surface colonization. No angioinvasion was identified. The presence of organisms infiltrating the necrotic mucosal tissue, together with obstructing fungal plaques visualized bronchoscopically, supported invasive infection and excluded mere airway colonization. Antifungal therapy was administered, resulting in the complete resolution of tracheal necrosis and stenosis on follow-up bronchoscopy. Despite recovery from fungal infection, the patient subsequently developed septic shock secondary to Klebsiella pneumoniae bacteremia and died. This case illustrates a rare presentation of C. auris tracheal infection leading to airway necrosis in an immunocompromised, mechanically ventilated patient. Early diagnosis through bronchoscopy, culture, and histopathology, combined with timely antifungal therapy, is critical for management. The case emphasizes the diagnostic and therapeutic challenges posed by multidrug-resistant fungal infections in critically ill patients with COVID-19.
Insights
A rare case of airway-obstructing tracheobronchial disease caused by the multidrug-resistant fungus Candida auris was identified in a critically ill COVID-19 patient. Early diagnosis and antifungal therapy led to resolution of the fungal infection.
Area of Science:
- Infectious Diseases
- Critical Care Medicine
- Pulmonology
Background:
- Candida auris is an emerging multidrug-resistant fungal pathogen causing significant morbidity and mortality, especially in critically ill and immunocompromised individuals.
- Tracheobronchial disease due to Candida auris is a rare and previously unreported presentation.
- The case involves an 80-year-old woman with multiple comorbidities, including myelofibrosis, who presented with severe COVID-19 pneumonia.
More Related Videos
06:43Studying Microbial Communities In Vivo: A Model of Host-mediated Interaction Between Candida Albicans and Pseudomonas Aeruginosa in the Airways
Published on: January 13, 2016
03:24Author Spotlight: Enhancing Candida albicans Detection in Catheter Infections Using Fluorescent Protein Tagging
Published on: March 22, 2024
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Acute Respiratory Failure-III
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Pneumonia III: Complications and Assessment